Using normative modelling to detect disease progression in mild cognitive impairment and Alzheimer's disease in a cross-sectional multi-cohort study.
Aged
Alzheimer Disease
/ diagnostic imaging
Brain
/ diagnostic imaging
Case-Control Studies
Cognitive Dysfunction
/ diagnostic imaging
Cohort Studies
Cross-Sectional Studies
Disease Progression
Female
Humans
Machine Learning
Male
Middle Aged
Models, Statistical
Neural Networks, Computer
Neuroimaging
/ methods
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
03 08 2021
03 08 2021
Historique:
received:
20
02
2021
accepted:
22
06
2021
entrez:
4
8
2021
pubmed:
5
8
2021
medline:
10
11
2021
Statut:
epublish
Résumé
Normative modelling is an emerging method for quantifying how individuals deviate from the healthy populational pattern. Several machine learning models have been implemented to develop normative models to investigate brain disorders, including regression, support vector machines and Gaussian process models. With the advance of deep learning technology, the use of deep neural networks has also been proposed. In this study, we assessed normative models based on deep autoencoders using structural neuroimaging data from patients with Alzheimer's disease (n = 206) and mild cognitive impairment (n = 354). We first trained the autoencoder on an independent dataset (UK Biobank dataset) with 11,034 healthy controls. Then, we estimated how each patient deviated from this norm and established which brain regions were associated to this deviation. Finally, we compared the performance of our normative model against traditional classifiers. As expected, we found that patients exhibited deviations according to the severity of their clinical condition. The model identified medial temporal regions, including the hippocampus, and the ventricular system as critical regions for the calculation of the deviation score. Overall, the normative model had comparable cross-cohort generalizability to traditional classifiers. To promote open science, we are making all scripts and the trained models available to the wider research community.
Identifiants
pubmed: 34344910
doi: 10.1038/s41598-021-95098-0
pii: 10.1038/s41598-021-95098-0
pmc: PMC8333350
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
15746Subventions
Organisme : NIA NIH HHS
ID : P30 AG066444
Pays : United States
Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : R01 AG021910
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG063153
Pays : United States
Organisme : Wellcome Trust
ID : WT213038/Z/18/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 208519/Z/17/Z
Pays : United Kingdom
Organisme : NCRR NIH HHS
ID : U24 RR021382
Pays : United States
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : R01 AG073949
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG003991
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG005681
Pays : United States
Organisme : NIMH NIH HHS
ID : P50 MH071616
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG026276
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG024904
Pays : United States
Informations de copyright
© 2021. The Author(s).
Références
Neuroimage. 2013 Apr 15;70:33-6
pubmed: 23274184
Neuroimage. 2014 Aug 15;97:333-48
pubmed: 24742919
Biostatistics. 2007 Jan;8(1):118-27
pubmed: 16632515
Int J Epidemiol. 2008 Apr;37(2):234-44
pubmed: 18381398
Hum Brain Mapp. 2021 Jun 1;42(8):2332-2346
pubmed: 33738883
Neuroimage. 2013 Oct 15;80:62-79
pubmed: 23684880
Alzheimers Dement. 2009 Jul;5(4):307-17
pubmed: 19560101
J Neurol. 2010 Dec;257(12):2004-14
pubmed: 20632026
Neuroimage. 2006 Jul 1;31(3):968-80
pubmed: 16530430
Front Aging Neurosci. 2019 Sep 04;11:245
pubmed: 31551759
Neuron. 2002 Jan 31;33(3):341-55
pubmed: 11832223
Biol Psychiatry. 2016 Oct 1;80(7):552-61
pubmed: 26927419
Neuroimage. 2018 Apr 1;169:11-22
pubmed: 29203452
Alzheimers Dement. 2019 May;15(5):699-708
pubmed: 30737119
J Neurol Neurosurg Psychiatry. 2005 Jan;76(1):11-4
pubmed: 15607988
Hum Brain Mapp. 2019 Feb 15;40(3):944-954
pubmed: 30311316
Neuroimage. 2018 Feb 15;167:104-120
pubmed: 29155184
Nature. 2015 May 28;521(7553):436-44
pubmed: 26017442
Nat Neurosci. 2016 Nov;19(11):1523-1536
pubmed: 27643430
Curr Alzheimer Res. 2009 Apr;6(2):179-85
pubmed: 19355853
J Alzheimers Dis. 2011;26 Suppl 3:159-99
pubmed: 21971460
Neuroimage. 2018 Feb 1;166:400-424
pubmed: 29079522
Expert Rev Neurother. 2008 Nov;8(11):1691-702
pubmed: 18986240
Alzheimers Dement. 2005 Jul;1(1):55-66
pubmed: 17476317
Neuroimage. 2004 Aug;22(4):1754-66
pubmed: 15275931
Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Jun;4(6):567-578
pubmed: 30799285
Psychol Med. 2020 Jan;50(2):314-323
pubmed: 30782224
Ageing Res Rev. 2016 Sep;30:25-48
pubmed: 26827786
JAMA Psychiatry. 2018 Nov 1;75(11):1146-1155
pubmed: 30304337
Lancet. 2004 Jan 31;363(9406):392-4
pubmed: 15074306
Arch Neurol. 2001 Mar;58(3):397-405
pubmed: 11255443
PLoS Med. 2015 Mar 31;12(3):e1001779
pubmed: 25826379
Neuroimage. 2020 Oct 15;220:117127
pubmed: 32634595
Alzheimers Dement. 2010 May;6(3):239-46
pubmed: 20451872
Int Psychogeriatr. 2009 Aug;21(4):672-87
pubmed: 19470201
Neuroreport. 2002 Oct 28;13(15):1939-43
pubmed: 12395096
J Cogn Neurosci. 2007 Sep;19(9):1498-507
pubmed: 17714011
Mol Psychiatry. 2019 Oct;24(10):1415-1424
pubmed: 31201374
Clin Chem. 2010 Feb;56(2):248-53
pubmed: 19833838
Behav Neurol. 2009;21(1):21-8
pubmed: 19847042
Neuroimage. 2012 Aug 15;62(2):774-81
pubmed: 22248573
Neuroimage. 2007 Oct 1;37(4):1122-31
pubmed: 17683950